Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case-control study.

"Declarations Ethics approval and consent to participateThis study was retrospective and used existing clinico-biological data only. According to the ethics regulation and French law, all the included subjects were informed of the study. The informed consent was waived according to French law due to the retrospective nature of the study. All the medical data were anonymized. The database was registered with the Commission Nationale Informatique et Libertés (CNIL) registration number: 2203351v0. The study was approved by the local ethics committee CLEP, registration number AAA-2023-09047. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors."

"Trial registration Retrospectively registered. The database was registered with the Commission Nationale Informatique et Libertés (CNIL), registration number: 2203351v0. The study was approved by the local ethics committee CLEP, registration number: AAA-2023-09047"